RightFit Trial Directory

Breast Cancer clinical trials in Rochester, MN

25 recruiting breast cancer studies with a site in Rochester, MN.

All trials in Rochester, MN · All Breast Cancer trials

RecruitingPhase 3NCT07174336

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Sponsor: Eli Lilly and Company

Minneapolis, MN · Rochester, MN · Saint Louis Park, MN · +126 more sites

RecruitingPhase 1NCT07311993

Phase 1 Study of CLR 125 in Triple Negative Breast Cancer

Sponsor: Cellectar Biosciences, Inc.

Rochester, MN · +3 more sites

RecruitingPhase 2NCT05557877

Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer

Sponsor: Mayo Clinic

Rochester, MN · +4 more sites

RecruitingPhase 1NCT06999798

An Optimized Ultrasound Twinkling Marker for the Imaging of Lymph Nodes in Patients With Clinically Node-Positive Breast Cancer, The UTMOST2 Trial

Sponsor: Mayo Clinic

Rochester, MN

RecruitingNot applicableNCT07214532

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Sponsor: Natera, Inc.

Rochester, MN · +48 more sites

RecruitingPhase 3NCT06492616

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Sponsor: Stemline Therapeutics, Inc.

Albert Lea, MN · Mankato, MN · Minneapolis, MN · +173 more sites

RecruitingPhase not listedNCT05059444

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Sponsor: Guardant Health, Inc.

Rochester, MN · +32 more sites

RecruitingPhase 1 / Phase 2NCT06657222

First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

Sponsor: Gilead Sciences

Rochester, MN · +12 more sites

RecruitingPhase 3NCT05879926

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Sponsor: NRG Oncology

Aitkin, MN · Baxter, MN · Bemidji, MN · +1223 more sites

RecruitingPhase 3NCT06072612

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Sponsor: BriaCell Therapeutics Corporation

Rochester, MN · +78 more sites

RecruitingPhase 1NCT06488378

Phase Ib Study of Axatilimab in Combination With Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer

Sponsor: Dana-Farber Cancer Institute

Rochester, MN · +1 more sites

RecruitingPhase not listedNCT06557057

Impact of Aromatase Inhibitor Therapy on Glucose Homeostasis and Diabetes Risk

Sponsor: Mayo Clinic

Rochester, MN

RecruitingPhase 3NCT05812807

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Sponsor: Alliance for Clinical Trials in Oncology

Bemidji, MN · Brainerd, MN · Burnsville, MN · +825 more sites

RecruitingPhase 3NCT06748222

E-Mindfulness Approaches for Living After Breast Cancer

Sponsor: NRG Oncology

Brainerd, MN · Duluth, MN · Mankato, MN · +378 more sites

RecruitingPhase 1NCT06562192

Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers

Sponsor: Novartis Pharmaceuticals

Rochester, MN · +8 more sites

RecruitingPhase 3NCT05696626

Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

Sponsor: LeonaBio

Minneapolis, MN · Rochester, MN · +34 more sites

RecruitingPhase 3NCT04852887

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Sponsor: NRG Oncology

Albert Lea, MN · Burnsville, MN · +809 more sites

RecruitingPhase not listedNCT06953245

Collecting Patient-Reported Experiences With Radiation Dermatitis in Breast Cancer Patients Undergoing Radiotherapy

Sponsor: Mayo Clinic

Rochester, MN

RecruitingPhase 1 / Phase 2NCT06395519

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

Sponsor: 858 Therapeutics, Inc.

Rochester, MN · +13 more sites

RecruitingPhase not listedNCT04703244

Development of Patient Derived Xenografts (PDX) in Patients With Breast Cancer

Sponsor: Mayo Clinic

Rochester, MN

RecruitingPhase 3NCT06435429

A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer

Sponsor: Jazz Pharmaceuticals

Coon Rapids, MN · Rochester, MN · +46 more sites

RecruitingPhase not listedNCT04799535

Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring

Sponsor: Mayo Clinic

Rochester, MN

RecruitingPhase 1 / Phase 2NCT06682793

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

Sponsor: A2 Biotherapeutics Inc.

Rochester, MN · +9 more sites

RecruitingPhase 1 / Phase 2NCT05824975

A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

Sponsor: GI Innovation, Inc.

Rochester, MN · +4 more sites

Not yet recruitingPhase 3NCT07723469

Phase 3 Trial of SRG-514 Administered Intraoperatively to Patients Undergoing Breast-Conserving Surgery

Sponsor: SURGE Therapeutics

Rochester, MN · +2 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.